secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEKTAR THERAPEUTICS (NKTR)
CIK:        0000906709
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001213900-23-047824
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Nektar Therapeutics stockholders approve all proposals at 2023 annual meeting
-----------------------------------------------------------------------------

- Elected Myriam J. Curet and Howard W. Robin to Board with 86.0M and 131.4M votes for, respectively.
- Approved amendment to 2017 Plan to increase authorized shares by 12,000,000 (128.2M for).
- Ratified Ernst & Young as fiscal 2023 auditor (152.2M for).
- Advisory say-on-pay approved (114.5M for); frequency set at 1 year (131.8M for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/906709/000121390023047824/0001213900-23-047824-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/906709/000121390023047824/ea180076-8k_nektar.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-047824

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer